Researchers reviewed the impact of prehabilitation on several surgery outcomes measures in patients with colorectal cancer.

Minimal residual disease negativity was achieved at a significantly higher rate with venetoclax-based therapies, supporting its role in CLL.

The guidelines recommend against using anti-PD-(L)1 agents, with or without platinum chemotherapy, for patients who have progressive disease on EGFR TKIs. The American Society of Clinical Oncology ...

The median overall survival was 16.85 months in the mirvetuximab soravtansine arm and 13.34 months in the chemotherapy arm. Mirvetuximab soravtansine improves overall survival (OS) over ...

Mothers with a newborn with congenital heart disease also have increased risk of cancer. HealthDay News — Children with congenital heart disease (CHD) have increased risk of developing cancer ...

Investigators proposed novel PSA thresholds for prostate cancer biochemical recurrence: PSA nadir plus 0.5 ng/mL after radiation therapy and PSA 0.5 ng/mL or higher with a PSA doubling time of 9 ...

Researchers sought to determine whether using HRD sources for HSCT would be effective for pediatric patients with hematologic cancers compared with UCB sources.

Pediatric patients with ALL were found to experience deficits in their motor skills between at least 1 month and 4 years after completing treatment.